| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | NEUTRAL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.48▼ | 5.54▼ | 5.48▼ | 5.71▼ | 4.76▲ |
| MA10 | 5.51▼ | 5.44▲ | 5.54▼ | 5.27▲ | 4.61▲ |
| MA20 | 5.51▼ | 5.54▼ | 5.53▼ | 4.52▲ | 5.07▲ |
| MA50 | 5.41▲ | 5.53▼ | 5.37▲ | 4.77▲ | 9.30▼ |
| MA100 | 5.53▼ | 5.34▲ | 4.78▲ | 5.67▼ | N/A |
| MA200 | 5.52▼ | 4.71▲ | 4.32▲ | 9.27▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.016▼ | 0.000▲ | -0.028▼ | 0.194▲ | 0.284▲ |
| RSI | 47.460▼ | 47.659▼ | 49.431▼ | 60.054▲ | 43.420▼ |
| STOCH | 39.986 | 65.167 | 25.214 | 85.870▲ | 33.440 |
| WILL %R | -64.000 | -71.795 | -71.795 | -24.532▲ | -39.233 |
| CCI | -161.046▼ | -12.777 | -53.455 | 67.266 | 94.046 |
|
Saturday, March 28, 2026 06:38 AM
Aardvark Therapeutics Inc. (NASDAQ:AARD) is one of the penny stocks with potential to rise 1000 percent. Aardvark Therapeutics said on March 23, 2026, that it had voluntarily paused its Phase 3 HERO ...
|
|
Thursday, March 12, 2026 07:00 AM
NEW YORK, March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aardvark Therapeutics, Inc. ("Aardvark" or the "Company") (NYSE: AARD). Such investors are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 07/07/26 | 5.71 | 5.71 | 5.24 | 5.46 | 254,395 |
| 06/07/26 | 5.59 | 6.05 | 5.46 | 5.99 | 187,502 |
| 02/07/26 | 5.58 | 5.74 | 5.19 | 5.70 | 210,840 |
| 01/07/26 | 5.69 | 5.99 | 5.29 | 5.62 | 241,624 |
| 30/06/26 | 5.15 | 5.77 | 5.0501 | 5.76 | 227,625 |
| 29/06/26 | 4.87 | 5.20 | 4.71 | 5.18 | 166,335 |
| 26/06/26 | 5.10 | 5.53 | 4.63 | 4.79 | 1,383,948 |
| 25/06/26 | 5.05 | 5.30 | 4.82 | 5.06 | 233,141 |
| 24/06/26 | 4.26 | 5.15 | 4.24 | 4.96 | 308,317 |
| 23/06/26 | 4.06 | 4.445 | 4.055 | 4.23 | 111,391 |
|
|
||||
|
|
||||
|
|